Akari Therapeutics Plc (AKTX): Price and Financial Metrics
AKTX Price/Volume Stats
| Current price | $1.47 | 52-week high | $4.40 |
| Prev. close | $1.57 | 52-week low | $1.08 |
| Day low | $1.46 | Volume | 97,900 |
| Day high | $1.68 | Avg. volume | 19,547 |
| 50-day MA | $2.63 | Dividend yield | N/A |
| 200-day MA | $2.54 | Market Cap | 17.85M |
AKTX Stock Price Chart Interactive Chart >
Akari Therapeutics Plc (AKTX) Company Bio
Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, engages in the development and commercialization of therapeutics to treat rare and orphan autoimmune and inflammatory diseases. The company is based in London, United Kingdom.
AKTX Price Returns
| 1-mo | -31.09% |
| 3-mo | -61.72% |
| 6-mo | -24.62% |
| 1-year | -51.00% |
| 3-year | -94.86% |
| 5-year | -95.98% |
| YTD | -52.88% |
| 2023 | -66.80% |
| 2022 | -68.67% |
| 2021 | -18.92% |
| 2020 | 5.71% |
| 2019 | 11.46% |
Loading social stream, please wait...